Ewa Kurzejamska
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Peripheral lysosome levels dictate mTORC1 inactivation even when catabolically impaired.
Journal: Cell communication and signaling : CCS
Published: June 05, 2025
An activin receptor-like kinase 1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases.
Journal: The Journal of clinical investigation
Published: June 07, 2024
Mouse CCL9 Chemokine Acts as Tumor Suppressor in a Murine Model of Colon Cancer.
Journal: Current issues in molecular biology
Published: February 28, 2023
The Journey of Cancer Cells to the Brain: Challenges and Opportunities.
Journal: International journal of molecular sciences
Published: December 22, 2022
Exercise reduces intramuscular stress and counteracts muscle weakness in mice with breast cancer.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 09, 2021
Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors.
Journal: International journal of molecular sciences
Published: December 09, 2018
Locally Transplanted CD34+ Bone Marrow-Derived Cells Contribute to Vascular Healing After Vascular Injury.
Journal: Transplantation proceedings
Published: October 27, 2016
C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation.
Journal: Oncogenesis
Published: August 27, 2014
Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 22, 2014
Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 20, 2013
MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Journal: Oncogene
Published: January 25, 2013
Last Updated: 09/26/2026